By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche today reported 2011 revenue growth of 6 percent at constant exchange rates for its diagnostics division including a 4 percent increase in sales for molecular diagnostic products.

The Swiss drugs, diagnostics, and research products giant reported total diagnostics sales of CHF 9.74 billion ($10.65 billion). Though the firm reported growth at constant exchange rates, in Swiss francs its diagnostics sales were down 7 percent from CHF 10.42 billion a year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.